CAS 1443437-74-8

Fórmula: C23H21ClN2O3

InChI: InChI=1S/C23H21ClN2O3/c24-19-8-10-20(11-9-19)25-22(27)18-6-2-12-26(15-18)23(28)17-5-1-4-16(14-17)21-7-3-13-29-21/h1,3-5,7-11,13-14,18H,2,6,12,15H2,(H,25,27)

Chave InChI: HERLZBNILRVHQN-UHFFFAOYSA-N

SMILES: C1CC(CN(C1)C(=O)C2=CC=CC(=C2)C3=CC=CO3)C(=O)NC4=CC=C(C=C4)Cl

N-(4-Chlorophenyl)-1-[3-(2-Furanyl)Benzoyl]-3-Piperidinecarboxamide

CAS: 1443437-74-8

N-(4-Chlorophenyl)-1-[3-(2-Furanyl)Benzoyl]-3-Piperidinecarboxamide

Fórmula: C₂₃H₂₁ClN₂O₃

Pureza: 97%

Peso molecular: 408.88

Ref: 54-OR1025996

N-(4-Chlorophenyl)-1-[3-(2-Furanyl)Benzoyl]-3-Piperidinecarboxamide

CAS: 1443437-74-8

Fórmula: C₂₃H₂₁ClN₂O₃

Pureza: 97%

Cor e Forma: Solid

Peso molecular: 408.8774

Ref: IN-DA001JDD

CCG-203971

CAS: 1443437-74-8

CCG-203971

Fórmula: C₂₃H₂₁ClN₂O₃

Pureza: ≥98%

Peso molecular: 408.88

Ref: 54-BUP13718

CCG-203971

CAS: 1443437-74-8

N-(4-Chlorophenyl)-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

Fórmula: C₂₃H₂₁ClN₂O₃

Pureza: 97%

Peso molecular: 408.88

Ref: IN-DG748511

CCG-203971

CAS: 1443437-74-8

CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.

Fórmula: C₂₃H₂₁ClN₂O₃

Pureza: 98.82% - 99.50%

Cor e Forma: Solid

Peso molecular: 408.88

Ref: TM-T4306

3-PIPERIDINECARBOXAMIDE, N-(4-CHLOROPHENYL)-1-[3-(2-FURANYL)BENZOYL]-

CAS: 1443437-74-8

Pureza: 98%

Peso molecular: 408.8800049

Ref: 10-F828410

CCG 203971

CAS: 1443437-74-8

Inhibits MRTF-SRF transcriptional pathway

Fórmula: C₂₃H₂₁ClN₂O₃

Pureza: Min. 95%

Peso molecular: 408.88 g/mol

Ref: 3D-FC76600